medac – diagnostics and treatment from a single source
medac GmbH is the only German pharmaceutical company to offer both diagnostic and therapeutic agents that have been developed and produced in-house. This creates very good conditions for customised medicine in the development and continuous improvement of active substances. Precise, patient-based diagnostics are decisively important for the optimisation of therapeutic measures and maximum therapy success.
medac Diagnostics Division
Sixty employees are responsible for the development, production and marketing of in-vitro diagnostic agents (IVDs) in medac’s Diagnostics Division. These products involve standardised methods and reagents used in specialist laboratories to test patient samples and identify diseases. Blood, cerebrospinal fluid, urine and tissue samples are all examined.
medac GmbH specialises in diagnostics for the fields of infection, cancer and life sciences research and works for non-hospital laboratory physicians, hospital laboratories and research institutions.
medac – specialist in infection diagnostics
medac has tens of years of experience in the development of diagnostic agents to detect diseases caused by bacteria, viruses, parasites or fungi.
medac’s diagnosticians provide laboratories with modern microbiological, molecular biological and immunohistochemical methods for the identification of the acute phase of an infective disease. These allow direct detection of a wide range of pathogens.
To investigate the stage of a disease, the immunological defence response or the success of a vaccination, medac supplies IVDs to determine (assay) pathogen-specific antibodies. Serological enzyme immunoassays to test for infection meet the highest quality requirements with the detection procedures patented by medac.
The principal fields of application for the products used for infection diagnostics are reproductive medicine, diagnostics for sexually transmitted diseases, diagnostics for pregnancy and transplants, and diagnostics for tick-borne diseases.
medac - specialist in cancer diagnostics
In the field of oncological diagnostics, medac focuses on the detection and differentiation of tumour tissue using specific methods, such as immunohistochemistry. These make it possible to see tumour proteins under the microscope. The results frequently provide valuable information about the individual characteristics of the tumour, which assist doctors in selecting the appropriate treatment for the patient.
medac supplies more than 4,000 individual reagents of tested and certified quality for tumour diagnostics.
medac Diagnostics Division also makes innovative contributions to research and development projects by means of the development of diagnostic tools for monitoring the efficacy of medicines in clinical therapeutic trials.
medac – partner for life sciences research
The highly qualified team of specialists, equipped with the comprehensive medac portfolio of antibodies and detection reagents, is available to provide advice on technical application problems relating to the wide range of methods used in life sciences research and the development of new diagnostic products in universities, research institutions and biotech companies.
medac – quality management for the highest demands
In-depth diagnostic evaluations, independent expert opinions from opinion-formers and numerous scientific publications are proof of the very high sensitivity and specificity and the diagnostic reliability of medac products. All in-vitro diagnostics from medac GmbH have held the CE certificate issued by TÜV from as far back as 2000.
medac – competence and service
medac’s Diagnostics Division employees place particular value on the continuous professional support of doctors and technical staff in customer laboratories. In addition to answering questions and helping solve problems within the context of routine diagnostics, scientific information and continuing professional development are all part of the service provided.